Stuart A. Randle - Dec 31, 2022 Form 5 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRA	Stock Option (Right to Buy)	Award		+45K			45K	May 19, 2022	Common Stock	45K	$0.59	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares underlying the option vest in 48 equal monthly installments beginning on September 16, 2021.
F2	This option was issued pursuant to the terms of a business combination agreement involving the issuer and Comera Life Sciences, Inc. in exchange for a comparable option previously issued by such company.